Menu
Medical Condition
Endocrinology & Metabolism
Endocrinology & Metabolism ICD-10: E23.6_4

Primary Empty Sella Syndrome

Herniation of the subarachnoid space into the sella turcica, flattening the pituitary gland.

Medical Disclaimer
This condition guide is intended for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider regarding any symptoms or medical conditions.

Clinical Assessment & Protocol

Typical Presentation (HPI)

Often asymptomatic, but can present with headaches or mild hypopituitarism.

General Examination

Usually normal; requires endocrine workup to rule out hormonal deficiencies.

Treatment Protocol

Observation and symptom management; hormone replacement if deficiency exists.

Patient Education

Reassurance that this is often an incidental finding without clinical significance.

Systemic & Specialized Examinations

Cardiovascular

EN: S1, S2 present. No murmurs. AR: صوتا القلب الأول والثاني طبيعيان. لا توجد نفخات.

Respiratory

EN: Lungs clear to auscultation. AR: الرئتان صافيتان عند التسمع.

Gastrointestinal

EN: Abdomen soft, non-tender. AR: البطن لين ولا يوجد ألم.

Neurological

EN: Alert, oriented x3. No focal deficits. AR: المريض واعي ومدرك. لا يوجد عجز عصبي بؤري.

Dermatological

EN: Unremarkable or not routinely indicated. AR: طبيعي أو غير مطلوب روتينياً.

Psychiatric

EN: Unremarkable or not routinely indicated. AR: طبيعي أو غير مطلوب روتينياً.

OB/GYN

EN: Unremarkable or not routinely indicated. AR: طبيعي أو غير مطلوب روتينياً.

Ophthalmic

EN: Unremarkable or not routinely indicated. AR: طبيعي أو غير مطلوب روتينياً.

Dental

EN: Unremarkable or not routinely indicated. AR: طبيعي أو غير مطلوب روتينياً.

Primary Empty Sella Syndrome: A Comprehensive Clinical Guide

1. Comprehensive Introduction & Overview

Primary Empty Sella Syndrome (PESS) is a clinical and radiological diagnosis defined by the herniation of the subarachnoid space into the sella turcica, leading to the remodeling of the sella and the flattening of the pituitary gland against the sellar floor.

Unlike secondary empty sella, which results from the surgical removal, radiation therapy, or infarction (e.g., Sheehan’s syndrome) of the pituitary gland, Primary Empty Sella Syndrome occurs in the absence of prior pituitary pathology or intervention. While historically considered an incidental radiological finding, modern clinical perspectives acknowledge that a subset of patients presents with significant neuro-endocrine and neurological sequelae.

Clinical Significance

The sella turcica is the bony structure at the base of the skull that houses the pituitary gland. In PESS, the diaphragm sellae—the dural fold that covers the sella—is either incompetent or absent. This allows cerebrospinal fluid (CSF) to exert chronic pressure on the pituitary gland, pushing it into a thin layer of tissue against the sellar walls.


2. Technical Specifications & Pathophysiology

The pathophysiology of PESS is multifactorial, involving anatomical, mechanical, and systemic factors that culminate in the characteristic "empty" appearance on imaging.

The Mechanism of Herniation

  1. Diaphragmatic Incompetence: The primary structural defect is a wide or deficient diaphragm sellae. This creates a direct communication between the suprasellar cistern and the intrasellar space.
  2. Chronic Pulsatile Pressure: CSF pulsations act as a hydraulic force. Over time, this chronic pressure remodels the bony sella, causing it to enlarge (ballooning) and forcing the pituitary gland to flatten.
  3. The "Empty" Appearance: On MRI, the sella appears largely filled with CSF, with the pituitary gland occupying less than 50% of the sellar volume.

Key Contributing Factors

  • Increased Intracranial Pressure (ICP): Many patients with PESS present with signs of benign intracranial hypertension (pseudotumor cerebri).
  • Obesity and Metabolic Syndrome: There is a high correlation between PESS and obesity, particularly in females. Increased intra-abdominal and intrathoracic pressure may contribute to elevated CSF pressure.
  • Hormonal Milieu: Elevated estrogen levels are hypothesized to play a role in the connective tissue laxity of the diaphragm sellae.
Factor Impact on PESS Progression
CSF Pressure Drives the expansion of the sella turcica.
Diaphragm Sellae Incompetence allows subarachnoid space herniation.
Pituitary Tissue Compressed and flattened, yet often functional.
Bony Remodeling Long-term pressure leads to sellar floor thinning.

3. Clinical Indications & Presentation

PESS is often discovered incidentally during neuroimaging for headaches or unrelated neurological symptoms. However, when symptomatic, the clinical presentation is diverse.

Typical Clinical Presentation

  • Headaches: Often chronic, non-specific, or associated with intracranial hypertension.
  • Endocrine Dysfunction: While most patients are euthyroid and hormonally normal, a significant minority experience mild pituitary hormone deficiencies.
  • Visual Disturbances: Though rare, if the chiasm herniates into the sella (chiasmopexy), patients may report visual field defects or blurring.
  • Hyperprolactinemia: Mild elevations in prolactin are common, often due to the "stalk effect" (compression of the pituitary stalk impeding dopamine delivery).

Diagnostic Staging/Grading (Simplified)

While no universal staging system exists, clinicians often categorize the severity based on pituitary compression:
1. Grade I: Minimal pituitary compression; incidental finding.
2. Grade II: Significant flattening, but normal endocrine function.
3. Grade III: Significant flattening with confirmed hypopituitarism or symptomatic visual changes.


4. Differential Diagnosis

Distinguishing PESS from other sellar pathologies is critical, as the management pathways differ significantly.

  • Pituitary Adenoma: Often exhibits mass effect and contrast enhancement patterns distinct from CSF.
  • Craniopharyngioma: Typically cystic or calcified; usually shows solid components on MRI.
  • Lymphocytic Hypophysitis: An inflammatory condition that may mimic mass effect but shows different signal intensities on T1/T2 weighted MRI.
  • Arachnoid Cyst: A fluid-filled lesion that may have a distinct capsule compared to the diffuse CSF density of PESS.

Diagnostic Workup Table

Test Purpose
MRI (Brain/Pituitary) Gold standard; visualizes the "empty" sella and chiasm.
Hormone Panel TSH, Free T4, Prolactin, IGF-1, ACTH, Cortisol.
Visual Field Testing Perimetry to rule out chiasmal compression.
Lumbar Puncture Measured opening pressure to assess for intracranial hypertension.

5. Risks, Side Effects, and Management

The management of PESS is primarily conservative. Most patients do not require surgical intervention.

Risks and Complications

  • Hypopituitarism: Long-term compression can lead to central hypothyroidism, secondary adrenal insufficiency, or hypogonadism.
  • CSF Rhinorrhea: Extremely rare, but occurs if the thin sellar floor erodes, creating a fistula into the sphenoid sinus.
  • Visual Loss: Usually associated with "chiasmal herniation," requiring surgical correction.

Contraindications to Surgery

  • Surgery (e.g., sellar packing) is generally contraindicated in asymptomatic patients.
  • Surgery is only considered for proven CSF rhinorrhea or severe, progressive visual field loss that correlates with the anatomical findings.

6. FAQ: Frequently Asked Questions

1. Is Primary Empty Sella Syndrome a form of cancer?

No. PESS is a benign anatomical variant/condition. It is not a tumor, nor is it a precursor to pituitary cancer.

2. Will I lose my vision?

Visual loss is rare. It only occurs if the optic chiasm is pulled into the sella (chiasmopexy). Regular monitoring by an ophthalmologist is recommended if you have known chiasmal involvement.

3. Does PESS cause weight gain?

PESS is frequently associated with obesity, but it is generally considered that obesity (and associated metabolic factors) contributes to the development of PESS, rather than PESS causing obesity.

4. Do I need surgery for an empty sella?

Rarely. Surgery is reserved for patients with clear complications such as CSF leakage or significant visual impairment that cannot be managed otherwise.

5. Can PESS cause infertility?

If PESS leads to pituitary hormone deficiencies (such as low LH/FSH), it can impact fertility. Hormonal replacement therapy can usually manage these effects.

6. Is this condition hereditary?

There is no strong evidence that PESS is inherited. It is primarily considered a condition related to anatomical variations and intracranial pressure dynamics.

7. Why do I have headaches with PESS?

Headaches are often linked to increased intracranial pressure (pseudotumor cerebri), which is a common comorbidity. Treatment focuses on managing the pressure rather than the sella itself.

8. What is the "Stalk Effect"?

The pituitary stalk carries dopamine from the hypothalamus to the pituitary gland. If the stalk is stretched or compressed by the herniating subarachnoid space, dopamine delivery is reduced, which can cause mild elevation in prolactin levels.

9. How often should I have follow-up MRIs?

If you are asymptomatic, follow-up imaging is often unnecessary after the initial diagnosis. If you have endocrine or visual symptoms, follow-up frequency is determined by your endocrinologist or neurologist.

10. Can I live a normal life with PESS?

Yes. The vast majority of individuals with PESS lead entirely normal, healthy lives and may never even know they have the condition unless they undergo an MRI for an unrelated reason.


7. Long-Term Prognosis

The prognosis for Primary Empty Sella Syndrome is excellent. In the absence of severe hormonal deficits or visual impairment, the condition is considered clinically stable.

Long-Term Management Strategy:

  • Endocrine Monitoring: Annual blood work to ensure pituitary function remains stable.
  • Symptom Tracking: Patients should monitor for signs of hormonal deficiency, such as unexplained fatigue, cold intolerance, or changes in menstrual cycles.
  • Weight Management: Given the association with intracranial pressure, weight loss is often recommended as a preventative strategy to maintain healthy CSF dynamics.

Conclusion

Primary Empty Sella Syndrome remains a fascinating intersection of neuroradiology and clinical endocrinology. While the radiological image of an "empty" sella may seem alarming, the reality is that the pituitary gland often continues to function adequately despite its compressed appearance. Expert clinical management involves distinguishing between incidental findings and symptomatic disease, ensuring that patients receive appropriate monitoring without the burden of unnecessary medical intervention.


Disclaimer: This guide is for educational purposes and does not constitute medical advice. Always consult with a qualified neurologist or endocrinologist for the diagnosis and management of pituitary conditions.

Treatment & Management Options

Recommended Medications

Share this guide: